Salient to Investors: Martin Connaghan at Aberdeen Asset Mgmt said: Buying industrial stocks with stable revenue and selling health-care stocks as uncertainty about the global economy has caused cyclicals to lag pharma and other defensive stocks by a margin that is too wide to ignore. The outlook for cyclical stocks
READ MORE... →Salient to Investors: Rotating into defensive industries has been a losing strategy for the third straight year as personal spending, manufacturing and inflation have exceeded analyst forecasts. The median projection says Q2 GDP grew 3.5 percent. Inflows into health-care and utility ETFs exceed $3 billion in 2014 versus $580 million inflows
READ MORE... →Salient to Investors: Neil Woodford at Woodford Investment Mgmt is cautious on the global economy and is buying sectors resilient to economic downturns like drugmakers and cigarette makers. Read the full article at http://www.bloomberg.com/news/2014-07-06/woodford-s-cautious-stance-see-glaxo-bat-top-10-holdings.html Click here to receive free and immediate email alerts of the latest forecasts.
READ MORE... →